What is AARD's software and technology licenses, net?

AARD (AARD) reported software and technology licenses, net of $4.74M in Q1 2026.

How has AARD's software and technology licenses, net changed year-over-year?

AARD's software and technology licenses, net increased by 157.2% year-over-year, from $1.84M to $4.74M.

AARD AARD Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

AbbVieABBV

——

Relmada Therapeutics, Inc.RLMD

——

Aquestive Therapeutics, Inc.AQST

——

Arcus BiosciencesRCUS

——

Other financials

Income statement

See full

Revenue-—

Operating income-$22.5M-115%

Net income-$21.6M-132%

EPS (diluted)-$0.99-39.4%

Balance sheet

See full

Cash & equivalents$62.4M+136%

Total debt$336.0K-53.7%

Total equity$87.0M-42.3%

Total assets$98.6M-37.2%

Cash flow

See full

Operating cash flow-$18.9M-65.7%

CapEx--100%

Free cash flow-$16.8M-117%

Valuation

See full

Market cap$124.35M-58.6%

Enterprise value$62.25M-77.4%

Returns & leverage

See full

Return on equity-58.8%—

Debt / equity0×0.0×

Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AARD's software and technology licenses, net?: AARD (AARD) reported software and technology licenses, net of $4.74M in Q1 2026.
How has AARD's software and technology licenses, net changed year-over-year?: AARD's software and technology licenses, net increased by 157.2% year-over-year, from $1.84M to $4.74M.